<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02615535</url>
  </required_header>
  <id_info>
    <org_study_id>2015P002184</org_study_id>
    <nct_id>NCT02615535</nct_id>
  </id_info>
  <brief_title>Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury</brief_title>
  <official_title>Neurofeedback-enhanced Mindfulness Meditation for the Treatment of Affective and Attentional Disturbances in Patients With Traumatic Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>InteraXon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Spaulding Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spaulding Rehabilitation Hospital is conducting a research study evaluating the effectiveness
      of the brain-training product, MUSE, an EEG-guided neurofeedback device designed to assist in
      cultivating a relaxed, attentive state of mind during meditation. The investigators study
      aims to evaluate whether such a tool could be useful in treating persistent traumatic brain
      injury symptoms such as inattention, impulsivity, irritability, or dysregulated mood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty subjects in total will participate in this study. Subjects will be randomized to
      focused-attention meditation training with or without the neurofeedback device, MUSE.
      Subjects will be asked to practice ~10 min of daily meditation for 6-8 weeks.
      Neuropsychological testing will be performed at the beginning of the study and after six
      weeks of training. At this time point, those randomized to the non-MUSE group will be given a
      device and asked to train for an additional two weeks. At the conclusion of the study, all
      subjects will also undergo a brief telephone or in-person exit interview regarding their
      experiences using the MUSE device.

      Primary endpoint: change in Neurobehavioral Symptom Inventory

      Secondary endpoints: change in the following: Wechsler Adult Intelligence Scale-IV Digit Span
      and Symbol-Digit Coding, Trail-Making Test, Beck Anxiety Inventory, Beck Depression
      Inventory, Cognitive and Affective Mindfulness Scale-Revised, percentage of EEG activity
      associated with alpha, beta, or theta activity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Neurobehavioral Symptom Inventory</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Measures common symptoms after head injury. This scales ranges from 0-4 on 22 items, for a minimum score of 0 and a maximum score of 88. Higher scores mean a greater severity of symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Wechsler Adult Intelligence Scale-IV Digit Span</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Tests participants digit span, repeating forward sequences of digits from 2 to 8. Scale ranges from 0 to 16. Higher scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Wechsler Adult Intelligence Scale-IV Digit Symbol Coding</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>A subject is provided with a key matching nine numbers to nine unique symbols. Numbers are then provided in random order and subjects have 120 seconds to match as many numbers with symbols as possible. All correct responses are scored. Scores range from 0 to 135. Scores are later scaled from 1 to 19. Higher scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Trail Making Test</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Subjects are asked to sequence numbers and letters represented on a page as quickly as then can. Results are measured in seconds, ranging from 0 (hypothetically) to an infinite number (hypothetically). Results are scaled from 1 to 19. Lower scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Beck Anxiety Inventory</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Subjects rate on a 0-3 likert scales responses to questions about anxiety. Scores range from 0-63. Lower scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Beck Depression Inventory-II</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Subjects respond to questions on a Likert scale from 0-3 regarding depressive symptoms. There are 21 items. Scores range from 0-63. Lower scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cognitive and Affective Mindfulness Scale-Revised</measure>
    <time_frame>baseline and six weeks</time_frame>
    <description>Subjects answer questions regarding mindfulness on a Likert Scale from 1-4. There are twelve questions total. Scores range from 4-48. Higher scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Percentage of EEG Activity Associated With Alpha, Beta, and Theta Rhythms as Measured by Surface Electrodes on the MUSE Device</measure>
    <time_frame>baseline and at six weeks</time_frame>
    <description>Change in &quot;percent Calm&quot; as determined by Muse device. Equations behind this algorithm to determine &quot;Calm&quot; are proprietary and were not shared by the device manufacturer. Ranges from 0% to 100%. Higher scores mean a better outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>EEG neurofeedback-assisted meditation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-EEG feedback-assisted meditation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG neurofeedback-assisted meditation</intervention_name>
    <description>meditation with auditory feedback regarding EEG status</description>
    <arm_group_label>EEG neurofeedback-assisted meditation</arm_group_label>
    <other_name>MUSE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-EEG feedback-assisted meditation</intervention_name>
    <description>meditation without auditory feedback regarding EEG status</description>
    <arm_group_label>Non-EEG feedback-assisted meditation</arm_group_label>
    <other_name>MUSE without EEG feedback</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. history of mild-moderate traumatic brain injury

          2. impaired attention or concentration

          3. &gt;1 year since traumatic brain injury

          4. ability to participate in neurofeedback and mindfulness meditation

          5. daily access to a smart phone

          6. on stable dosage of neuropsychological medications with no significant changes planned
             for the duration of the study

          7. no prior history of a meditation practice

        Exclusion Criteria:

          1. severe mental illness or psychological symptoms (severe depression, suicidality,
             disabling anxiety, PTSD, psychosis, dissociation)

          2. significant pre-morbid learning disability

          3. current or recent (in past year) history of significant drug or alcohol abuse

          4. medical illness severe enough to result in an attentional disorder

          5. neurodegenerative disease

          6. non-fluency in English.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mel B Glenn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spaulding Rehabilitation Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Hospital Boston</name>
      <address>
        <city>Charlestown</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brandmeyer T, Delorme A. Meditation and neurofeedback. Front Psychol. 2013 Oct 7;4:688. doi: 10.3389/fpsyg.2013.00688. eCollection 2013.</citation>
    <PMID>24109463</PMID>
  </reference>
  <reference>
    <citation>Chiesa A, Calati R, Serretti A. Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clin Psychol Rev. 2011 Apr;31(3):449-64. doi: 10.1016/j.cpr.2010.11.003. Epub 2010 Dec 1. Review.</citation>
    <PMID>21183265</PMID>
  </reference>
  <reference>
    <citation>Cicerone KD, Langenbahn DM, Braden C, Malec JF, Kalmar K, Fraas M, Felicetti T, Laatsch L, Harley JP, Bergquist T, Azulay J, Cantor J, Ashman T. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil. 2011 Apr;92(4):519-30. doi: 10.1016/j.apmr.2010.11.015. Review.</citation>
    <PMID>21440699</PMID>
  </reference>
  <reference>
    <citation>Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010 Apr;78(2):169-83. doi: 10.1037/a0018555.</citation>
    <PMID>20350028</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2015</study_first_posted>
  <results_first_submitted>August 9, 2019</results_first_submitted>
  <results_first_submitted_qc>November 19, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 6, 2019</results_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spaulding Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Mel B. Glenn</investigator_full_name>
    <investigator_title>Director of Outpatient and Community Brain Injury Rehabilitation</investigator_title>
  </responsible_party>
  <keyword>traumatic brain injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alprostadil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>If participants request their outcome data, we will provide this to them with a brief discussion of its meaning and limitations on interpretation.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/35/NCT02615535/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>EEG Neurofeedback-assisted Meditation</title>
          <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
        </group>
        <group group_id="P2">
          <title>Non-EEG Feedback-assisted Meditation</title>
          <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>EEG Neurofeedback-assisted Meditation</title>
          <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
        </group>
        <group group_id="B2">
          <title>Non-EEG Feedback-assisted Meditation</title>
          <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.3" spread="3.6"/>
                    <measurement group_id="B2" value="41.4" spread="4.7"/>
                    <measurement group_id="B3" value="45.4" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Neurobehavioral Symptom Inventory</title>
        <description>Measures common symptoms after head injury. This scales ranges from 0-4 on 22 items, for a minimum score of 0 and a maximum score of 88. Higher scores mean a greater severity of symptoms.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Neurobehavioral Symptom Inventory</title>
          <description>Measures common symptoms after head injury. This scales ranges from 0-4 on 22 items, for a minimum score of 0 and a maximum score of 88. Higher scores mean a greater severity of symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.2" spread="3"/>
                    <measurement group_id="O2" value="33.1" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.7" spread="2.8"/>
                    <measurement group_id="O2" value="24.6" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Wechsler Adult Intelligence Scale-IV Digit Span</title>
        <description>Tests participants digit span, repeating forward sequences of digits from 2 to 8. Scale ranges from 0 to 16. Higher scores mean a better outcome.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Wechsler Adult Intelligence Scale-IV Digit Span</title>
          <description>Tests participants digit span, repeating forward sequences of digits from 2 to 8. Scale ranges from 0 to 16. Higher scores mean a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="0.7"/>
                    <measurement group_id="O2" value="11.2" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>six weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="0.6"/>
                    <measurement group_id="O2" value="11.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Wechsler Adult Intelligence Scale-IV Digit Symbol Coding</title>
        <description>A subject is provided with a key matching nine numbers to nine unique symbols. Numbers are then provided in random order and subjects have 120 seconds to match as many numbers with symbols as possible. All correct responses are scored. Scores range from 0 to 135. Scores are later scaled from 1 to 19. Higher scores mean a better outcome.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Wechsler Adult Intelligence Scale-IV Digit Symbol Coding</title>
          <description>A subject is provided with a key matching nine numbers to nine unique symbols. Numbers are then provided in random order and subjects have 120 seconds to match as many numbers with symbols as possible. All correct responses are scored. Scores range from 0 to 135. Scores are later scaled from 1 to 19. Higher scores mean a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.6" spread="1.2"/>
                    <measurement group_id="O2" value="11.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>six weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1" spread="1.1"/>
                    <measurement group_id="O2" value="12.5" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Trail Making Test</title>
        <description>Subjects are asked to sequence numbers and letters represented on a page as quickly as then can. Results are measured in seconds, ranging from 0 (hypothetically) to an infinite number (hypothetically). Results are scaled from 1 to 19. Lower scores mean a better outcome.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Trail Making Test</title>
          <description>Subjects are asked to sequence numbers and letters represented on a page as quickly as then can. Results are measured in seconds, ranging from 0 (hypothetically) to an infinite number (hypothetically). Results are scaled from 1 to 19. Lower scores mean a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="1"/>
                    <measurement group_id="O2" value="11.9" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>six weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3" spread="0.8"/>
                    <measurement group_id="O2" value="12.7" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Beck Anxiety Inventory</title>
        <description>Subjects rate on a 0-3 likert scales responses to questions about anxiety. Scores range from 0-63. Lower scores mean a better outcome.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Beck Anxiety Inventory</title>
          <description>Subjects rate on a 0-3 likert scales responses to questions about anxiety. Scores range from 0-63. Lower scores mean a better outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.9" spread="1.9"/>
                    <measurement group_id="O2" value="18.8" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>six weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5" spread="1.9"/>
                    <measurement group_id="O2" value="8.5" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Beck Depression Inventory-II</title>
        <description>Subjects respond to questions on a Likert scale from 0-3 regarding depressive symptoms. There are 21 items. Scores range from 0-63. Lower scores mean a better outcome.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Beck Depression Inventory-II</title>
          <description>Subjects respond to questions on a Likert scale from 0-3 regarding depressive symptoms. There are 21 items. Scores range from 0-63. Lower scores mean a better outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.9" spread="3.6"/>
                    <measurement group_id="O2" value="17" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>six weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1" spread="3.1"/>
                    <measurement group_id="O2" value="9.9" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Cognitive and Affective Mindfulness Scale-Revised</title>
        <description>Subjects answer questions regarding mindfulness on a Likert Scale from 1-4. There are twelve questions total. Scores range from 4-48. Higher scores mean a better outcome.</description>
        <time_frame>baseline and six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cognitive and Affective Mindfulness Scale-Revised</title>
          <description>Subjects answer questions regarding mindfulness on a Likert Scale from 1-4. There are twelve questions total. Scores range from 4-48. Higher scores mean a better outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.2" spread="2"/>
                    <measurement group_id="O2" value="24.7" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>six weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.3" spread="1.6"/>
                    <measurement group_id="O2" value="28.3" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Percentage of EEG Activity Associated With Alpha, Beta, and Theta Rhythms as Measured by Surface Electrodes on the MUSE Device</title>
        <description>Change in &quot;percent Calm&quot; as determined by Muse device. Equations behind this algorithm to determine &quot;Calm&quot; are proprietary and were not shared by the device manufacturer. Ranges from 0% to 100%. Higher scores mean a better outcome.</description>
        <time_frame>baseline and at six weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EEG Neurofeedback-assisted Meditation</title>
            <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
          </group>
          <group group_id="O2">
            <title>Non-EEG Feedback-assisted Meditation</title>
            <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Percentage of EEG Activity Associated With Alpha, Beta, and Theta Rhythms as Measured by Surface Electrodes on the MUSE Device</title>
          <description>Change in &quot;percent Calm&quot; as determined by Muse device. Equations behind this algorithm to determine &quot;Calm&quot; are proprietary and were not shared by the device manufacturer. Ranges from 0% to 100%. Higher scores mean a better outcome.</description>
          <units>percentage of &quot;Calm&quot;</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.7" spread="5.6"/>
                    <measurement group_id="O2" value="32" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>six weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.7" spread="7.6"/>
                    <measurement group_id="O2" value="43.7" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse effects from meditation were not anticipated. Subjects practiced meditation for six weeks each. If adverse effects occurred during the six weeks, they contacted our group. At our post-intervention assessment at six weeks, we asked specifically about adverse events. Adverse events were not monitored beyond the intervention period of six weeks.</time_frame>
      <desc>Definitions are consistent.</desc>
      <group_list>
        <group group_id="E1">
          <title>EEG Neurofeedback-assisted Meditation</title>
          <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
EEG neurofeedback-assisted meditation: meditation with auditory feedback regarding EEG status</description>
        </group>
        <group group_id="E2">
          <title>Non-EEG Feedback-assisted Meditation</title>
          <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Non-EEG feedback-assisted meditation: meditation without auditory feedback regarding EEG status</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ginger Polich</name_or_title>
      <organization>Spaulding Rehabilitation Hospital</organization>
      <phone>617 952 5000</phone>
      <email>ginger.polich@mgh.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

